Risk Factors for Immune-Related Adverse Events from Anti-PD-1/PD-L1 Treatment in an Asian Cohort of NSCLC Patients
16
Saved in:
Main Authors: | Huang, Y, Soon, YY, Aminkeng, F, Tay, SH, Ang, Y, Goh, BC, Wong, A, Soo, RA |
---|---|
Other Authors: | MEDICINE |
Format: | Conference or Workshop Item |
Published: |
ELSEVIER SCIENCE INC
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/245751 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients
by: Huang, Yiqing, et al.
Published: (2022) -
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
by: Ng K.Y.Y., et al.
Published: (2022) -
Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLC
by: Huang, Y, et al.
Published: (2023) -
Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature
by: Tay, Sen Hee, et al.
Published: (2022) -
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
by: Chuah, Samuel, et al.
Published: (2022)